相似文献
1
Chemo-enzymatic fluorination of unactivated organic compounds.
Nat Chem Biol. 2009 Jan;5(1):26-8. doi: 10.1038/nchembio.128. Epub 2008 Nov 16.
2
The bacterial P450 BM3: a prototype for a biocatalyst with human P450 activities.
Trends Biotechnol. 2007 Jul;25(7):289-98. doi: 10.1016/j.tibtech.2007.05.003. Epub 2007 May 29.
3
Screening of a minimal enriched P450 BM3 mutant library for hydroxylation of cyclic and acyclic alkanes.
Chem Commun (Camb). 2011 Jan 21;47(3):944-6. doi: 10.1039/c0cc02924f. Epub 2010 Nov 15.
4
Combinatorial alanine substitution enables rapid optimization of cytochrome P450BM3 for selective hydroxylation of large substrates.
Chembiochem. 2010 Dec 10;11(18):2502-5. doi: 10.1002/cbic.201000565.
5
Alkane metabolism by cytochrome P450 BM3.
Biochem Soc Trans. 1993 Nov;21(4):412S. doi: 10.1042/bst021412s.
6
Structure, dynamics, and function of the monooxygenase P450 BM-3: insights from computer simulations studies.
J Phys Condens Matter. 2015 Jul 15;27(27):273102. doi: 10.1088/0953-8984/27/27/273102. Epub 2015 Jun 10.
7
Regioselective hydroxylation of 17β-estradiol by mutants of CYP102A1 from Bacillus megaterium.
Biotechnol Lett. 2014 Dec;36(12):2501-6. doi: 10.1007/s10529-014-1628-9. Epub 2014 Aug 17.
8
Cytochrome P450 catalyzed oxidative hydroxylation of achiral organic compounds with simultaneous creation of two chirality centers in a single C-H activation step.
Angew Chem Int Ed Engl. 2014 Aug 11;53(33):8659-63. doi: 10.1002/anie.201310892. Epub 2014 Mar 3.
9
Protein engineering of the cytochrome P450 monooxygenase from Bacillus megaterium.
Methods Enzymol. 2004;388:208-24. doi: 10.1016/S0076-6879(04)88019-4.
10
Human P450-like oxidation of diverse proton pump inhibitor drugs by 'gatekeeper' mutants of flavocytochrome P450 BM3.
Biochem J. 2014 Jun 1;460(2):247-59. doi: 10.1042/BJ20140030.
引用本文的文献
1
Choose Your Own Adventure: A Comprehensive Database of Reactions Catalyzed by Cytochrome P450 BM3 Variants.
ACS Catal. 2024 Mar 29;14(8):5560-5592. doi: 10.1021/acscatal.4c00086. eCollection 2024 Apr 19.
2
Enzymkatalysierte späte Modifizierungen: Besser spät als nie.
Angew Chem Weinheim Bergstr Ger. 2021 Jul 26;133(31):16962-16993. doi: 10.1002/ange.202014931. Epub 2021 Mar 8.
3
Late-stage modification of bioactive compounds: Improving druggability through efficient molecular editing.
Acta Pharm Sin B. 2024 Mar;14(3):1030-1076. doi: 10.1016/j.apsb.2023.11.021. Epub 2023 Nov 18.
4
Computationally guided bioengineering of the active site, substrate access pathway, and water channels of thermostable cytochrome P450, CYP175A1, for catalyzing the alkane hydroxylation reaction.
Chem Sci. 2023 Dec 4;14(48):14316-14326. doi: 10.1039/d3sc02857g. eCollection 2023 Dec 13.
5
Non-Native Site-Selective Enzyme Catalysis.
Chem Rev. 2023 Aug 23;123(16):10381-10431. doi: 10.1021/acs.chemrev.3c00215. Epub 2023 Jul 31.
6
Late-stage C-H functionalization offers new opportunities in drug discovery.
Nat Rev Chem. 2021 Aug;5(8):522-545. doi: 10.1038/s41570-021-00300-6. Epub 2021 Jul 13.
7
Evidence for a High-Valent Iron-Fluoride That Mediates Oxidative C(sp)-H Fluorination.
JACS Au. 2023 Mar 3;3(3):919-928. doi: 10.1021/jacsau.3c00021. eCollection 2023 Mar 27.
8
Anaerobic Hydroxylation of C(sp)-H Bonds Enabled by the Synergistic Nature of Photoexcited Nitroarenes.
J Am Chem Soc. 2023 Feb 8;145(5):2794-2799. doi: 10.1021/jacs.2c13502. Epub 2023 Jan 25.
9
New F NMR methodology reveals structures of molecules in complex mixtures of fluorinated compounds.
Chem Sci. 2022 Feb 25;13(13):3766-3774. doi: 10.1039/d1sc06057k. eCollection 2022 Mar 30.
10
F-centred NMR analysis of mono-fluorinated compounds.
RSC Adv. 2022 Mar 30;12(16):10062-10070. doi: 10.1039/d1ra08046f. eCollection 2022 Mar 25.
本文引用的文献
1
Evolutionary history of a specialized p450 propane monooxygenase.
J Mol Biol. 2008 Nov 28;383(5):1069-80. doi: 10.1016/j.jmb.2008.06.060. Epub 2008 Jun 28.
2
Fluorine in pharmaceuticals: looking beyond intuition.
Science. 2007 Sep 28;317(5846):1881-6. doi: 10.1126/science.1131943.
3
Selective modulation of Abeta42 production in Alzheimer's disease: non-steroidal anti-inflammatory drugs and beyond.
Curr Pharm Des. 2006;12(33):4337-55. doi: 10.2174/138161206778793029.
4
Catalytic asymmetric fluorinations.
Org Biomol Chem. 2006 Jun 7;4(11):2065-75. doi: 10.1039/b603163c. Epub 2006 May 3.
5
Enantioselective alpha-hydroxylation of 2-arylacetic acid derivatives and buspirone catalyzed by engineered cytochrome P450 BM-3.
J Am Chem Soc. 2006 May 10;128(18):6058-9. doi: 10.1021/ja061261x.
6
Flavocytochrome P450 BM3: an update on structure and mechanism of a biotechnologically important enzyme.
Biochem Soc Trans. 2005 Aug;33(Pt 4):747-53. doi: 10.1042/BST0330747.
7
Synthesis and optical resolution of 2-aryl-2-fluoropropionic acids, fluorinated analogues of non-steroidal anti-inflammatory drugs (NSAIDs).
Chem Pharm Bull (Tokyo). 2005 May;53(5):524-8. doi: 10.1248/cpb.53.524.
8
Modern synthetic methods for fluorine-substituted target molecules.
Angew Chem Int Ed Engl. 2004 Dec 27;44(2):214-31. doi: 10.1002/anie.200460441.
9
Asymmetric fluorination, trifluoromethylation, and perfluoroalkylation reactions.
Chem Rev. 2004 Dec;104(12):6119-46. doi: 10.1021/cr030143e.
10
Fluorine in medicinal chemistry.
Chembiochem. 2004 May 3;5(5):637-43. doi: 10.1002/cbic.200301023.
Zotero 插件